Who
Nelson Sun
Officer
Company insider
Files Form 4 as: Chief Financial Officer, Aardvark Therapeutics.
In numbers
- Trades disclosed
- 12
- Buys
- 3
- Sells
- 2
- Bought
- $252K
- Sold
- $790K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 14 Feb 2025
- Last trade
- 11 Sep 2026
- Last filed
- 11 Sep 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Sep 2026filed 11 Sep 2026 | AARD Aardvark TherapeuticsBiotechnology | SEC FORM 4 Sold | $321K62,000 at $5.18 | filing |
| 11 Sep 2026filed 11 Sep 2026 | AARD Aardvark TherapeuticsBiotechnology | SEC FORM 4 Sold | $321K62,000 at $5.18 | filing |
| 10 Sep 2026filed 11 Sep 2026 | AARD Aardvark TherapeuticsBiotechnology | SEC FORM 4 Sold | $74K14,754 at $5.00 | filing |
| 10 Sep 2026filed 11 Sep 2026 | AARD Aardvark TherapeuticsBiotechnology | SEC FORM 4 Sold | $74K14,754 at $5.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | AARD Aardvark Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,549 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | AARD Aardvark Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,549 at $0.00 | filing |
| 11 Dec 2025filed 12 Dec 2025 | AARD Aardvark TherapeuticsBiotechnology | SEC FORM 4 Bought | $43K3,000 at $14.40 | filing |
| 9 Sep 2025filed 10 Sep 2025 | AARD Aardvark TherapeuticsBiotechnology | SEC FORM 4 Bought | $48K6,000 at $8.07 | filing |
| 11 Jun 2025filed 13 Jun 2025 | AARD Aardvark Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —209,826 at $0.00 | filing |
| 14 Feb 2025filed 19 Feb 2025 | AARD Aardvark Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —59,332 at $0.00 | filing |
| 14 Feb 2025filed 19 Feb 2025 | AARD Aardvark TherapeuticsBiotechnology | SEC FORM 4 Code C | —7,001 | filing |
| 14 Feb 2025filed 19 Feb 2025 | AARD Aardvark TherapeuticsBiotechnology | SEC FORM 4 Bought | $160K10,000 at $16.00 | filing |
News
Aardvark Therapeutics (NASDAQ:AARD) Insider Nelson Sun Sells 62,000 Sharestickerreport.com · 12 Sep 2026Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension TrialsAARD · manilatimes.net · 23 Oct 2026Aardvark Therapeutics (NASDAQ:AARD) Given New $4.00 Price Target at HC WainwrightAARD · dailypolitical.com · 20 Oct 2026Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Hub Group, Inc. (NASDAQ: HUBG); and Power Solutions International, Inc. (NASDAQ: PSIX): Grabar Law Office is Investigating Claims on Your BehalfAARD · mykxlg.com · 19 Oct 2026
1 headline in the last 90 days name Nelson Sun; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.